Amount raised
€23M
€23,080,459
Native amount
24,200,000 CHF
Stage
Series C
series c
Investors
0
Provenance & confidence
High confidenceAmount
24,200,000 CHF
ECB-at-date → €23M · rate 1.0486 on 2022-06-08
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0No investors disclosed for this round.
Date
Jun 2022
Round type
series c
Amount (EUR)
€23M
Other rounds
same companyRelated news
- BioVersys attracts CHF 24.2 million to develop clinical pipelinestartupticker.ch · 2022-06